 | • レポートコード：MRC2102QY11945 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の狂犬病ワクチン市場について種類別（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他）、用途別（接触前予防、接触後予防）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・狂犬病ワクチン市場の概要 ・世界の主要地域別狂犬病ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の狂犬病ワクチン市場規模2015-2026：種類別（ベロ細胞狂犬病ワクチン、BHK、ニワトリ胚細胞狂犬病ワクチン、その他） ・世界の狂犬病ワクチン市場規模2015-2026：用途別（接触前予防、接触後予防） ・狂犬病ワクチンの米国市場規模2015-2020 ・狂犬病ワクチンのヨーロッパ市場規模2015-2020 ・狂犬病ワクチンの中国市場規模2015-2020 ・狂犬病ワクチンの日本市場規模2015-2020 ・狂犬病ワクチンの東南アジア市場規模2015-2020 ・狂犬病ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・狂犬病ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・狂犬病ワクチンの市場動向・機会・課題 ・調査の結論 |
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China’s two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
Market Analysis and Insights: Global Rabies Vaccine Market
The global Rabies Vaccine market size is projected to reach US$ 1104.7 million by 2026, from US$ 873.1 million in 2020, at a CAGR of 4.0% during 2021-2026.
Global Rabies Vaccine Scope and Market Size
The global Rabies Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rabies Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Rabies Vaccine market is segmented into
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Other
Segment by Application, the Rabies Vaccine market is segmented into
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
The Rabies Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Rabies Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rabies Vaccine Market Share Analysis
Rabies Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rabies Vaccine business, the date to enter into the Rabies Vaccine market, Rabies Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
1 Rabies Vaccine Market Overview
1.1 Rabies Vaccine Product Scope
1.2 Rabies Vaccine Segment by Type
1.2.1 Global Rabies Vaccine Sales by Type (2020-2026)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Other
1.3 Rabies Vaccine Segment by Application
1.3.1 Global Rabies Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Rabies Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Rabies Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Rabies Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Rabies Vaccine Price Trends (2015-2026)
2 Rabies Vaccine Estimate and Forecast by Region
2.1 Global Rabies Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Rabies Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Rabies Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Rabies Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Rabies Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Rabies Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Rabies Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Rabies Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Rabies Vaccine Estimates and Projections (2015-2026)
2.4.3 China Rabies Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Rabies Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Rabies Vaccine Estimates and Projections (2015-2026)
2.4.6 India Rabies Vaccine Estimates and Projections (2015-2026)
3 Global Rabies Vaccine Competition Landscape by Players
3.1 Global Top Rabies Vaccine Players by Sales (2015-2020)
3.2 Global Top Rabies Vaccine Players by Revenue (2015-2020)
3.3 Global Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine as of 2019)
3.4 Global Rabies Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Rabies Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Rabies Vaccine Players (Opinion Leaders)
4 Global Rabies Vaccine Market Size by Type
4.1 Global Rabies Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Rabies Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Rabies Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Rabies Vaccine Price by Type (2015-2020)
4.2 Global Rabies Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Rabies Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Rabies Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Rabies Vaccine Price Forecast by Type (2021-2026)
5 Global Rabies Vaccine Market Size by Application
5.1 Global Rabies Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Rabies Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Rabies Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Rabies Vaccine Price by Application (2015-2020)
5.2 Global Rabies Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Rabies Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Rabies Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Rabies Vaccine Price Forecast by Application (2021-2026)
6 United States Rabies Vaccine Market Facts & Figures
6.1 United States Rabies Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Rabies Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Rabies Vaccine Sales Market Share by Application (2015-2020)
7 Europe Rabies Vaccine Market Facts & Figures
7.1 Europe Rabies Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Rabies Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Rabies Vaccine Sales Market Share by Application (2015-2020)
8 China Rabies Vaccine Market Facts & Figures
8.1 China Rabies Vaccine Sales Market Share by Company (2015-2020)
8.2 China Rabies Vaccine Sales Market Share by Type (2015-2020)
8.3 China Rabies Vaccine Sales Market Share by Application (2015-2020)
9 Japan Rabies Vaccine Market Facts & Figures
9.1 Japan Rabies Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Rabies Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Rabies Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Rabies Vaccine Market Facts & Figures
10.1 Southeast Asia Rabies Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Rabies Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Rabies Vaccine Sales Market Share by Application (2015-2020)
11 India Rabies Vaccine Market Facts & Figures
11.1 India Rabies Vaccine Sales Market Share by Company (2015-2020)
11.2 India Rabies Vaccine Sales Market Share by Type (2015-2020)
11.3 India Rabies Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Rabies Vaccine Business
12.1 GSK (Novartis)
12.1.1 GSK (Novartis) Corporation Information
12.1.2 GSK (Novartis) Business Overview
12.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK (Novartis) Rabies Vaccine Products Offered
12.1.5 GSK (Novartis) Recent Development
12.2 Sanofi-Pasteur
12.2.1 Sanofi-Pasteur Corporation Information
12.2.2 Sanofi-Pasteur Business Overview
12.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi-Pasteur Rabies Vaccine Products Offered
12.2.5 Sanofi-Pasteur Recent Development
12.3 Chengda
12.3.1 Chengda Corporation Information
12.3.2 Chengda Business Overview
12.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Chengda Rabies Vaccine Products Offered
12.3.5 Chengda Recent Development
12.4 Yisheng
12.4.1 Yisheng Corporation Information
12.4.2 Yisheng Business Overview
12.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Yisheng Rabies Vaccine Products Offered
12.4.5 Yisheng Recent Development
12.5 Prcmise
12.5.1 Prcmise Corporation Information
12.5.2 Prcmise Business Overview
12.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Prcmise Rabies Vaccine Products Offered
12.5.5 Prcmise Recent Development
12.6 VACN
12.6.1 VACN Corporation Information
12.6.2 VACN Business Overview
12.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 VACN Rabies Vaccine Products Offered
12.6.5 VACN Recent Development
12.7 Changsheng
12.7.1 Changsheng Corporation Information
12.7.2 Changsheng Business Overview
12.7.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Changsheng Rabies Vaccine Products Offered
12.7.5 Changsheng Recent Development
12.8 BCHT
12.8.1 BCHT Corporation Information
12.8.2 BCHT Business Overview
12.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 BCHT Rabies Vaccine Products Offered
12.8.5 BCHT Recent Development
12.9 Hissen
12.9.1 Hissen Corporation Information
12.9.2 Hissen Business Overview
12.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hissen Rabies Vaccine Products Offered
12.9.5 Hissen Recent Development
13 Rabies Vaccine Manufacturing Cost Analysis
13.1 Rabies Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Rabies Vaccine
13.4 Rabies Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Rabies Vaccine Distributors List
14.3 Rabies Vaccine Customers
15 Market Dynamics
15.1 Rabies Vaccine Market Trends
15.2 Rabies Vaccine Opportunities and Drivers
15.3 Rabies Vaccine Market Challenges
15.4 Rabies Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Rabies Vaccine Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Rabies Vaccine Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Rabies Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Rabies Vaccine Sales (K Units) by Region (2015-2020)
Table 5. Global Rabies Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Rabies Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Rabies Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Rabies Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Rabies Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Rabies Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Rabies Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Rabies Vaccine (K Units) of Key Companies (2015-2020)
Table 13. Global Rabies Vaccine Sales Share by Company (2015-2020)
Table 14. Global Rabies Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Rabies Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine as of 2019)
Table 17. Global Rabies Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Rabies Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Rabies Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Rabies Vaccine Players
Table 22. Global Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 23. Global Rabies Vaccine Sales Share by Type (2015-2020)
Table 24. Global Rabies Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Rabies Vaccine Price (K Units) by Type (2015-2020)
Table 26. Global Rabies Vaccine Sales Share by Type (2021-2026)
Table 27. Global Rabies Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Rabies Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Rabies Vaccine Price (K Units) by Type (2021-2026)
Table 30. Global Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 31. Global Rabies Vaccine Sales Share by Application (2015-2020)
Table 32. Global Rabies Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Rabies Vaccine Price (K Units) by Application (2015-2020)
Table 34. Global Rabies Vaccine Sales (K Units) by Application (2021-2026)
Table 35. Global Rabies Vaccine Sales Share by Application (2021-2026)
Table 36. Global Rabies Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Rabies Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Rabies Vaccine Price (K Units) by Application (2021-2026)
Table 39. United States Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 40. United States Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 42. United States Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 44. United States Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 46. Europe Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 48. Europe Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 50. Europe Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 52. China Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 54. China Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 56. China Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 58. Japan Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 60. Japan Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 62. Japan Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Rabies Vaccine Sales (K Units) by Company (2015-2020)
Table 70. India Rabies Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 72. India Rabies Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 74. India Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 75. GSK (Novartis) Corporation Information
Table 76. GSK (Novartis) Description and Business Overview
Table 77. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK (Novartis) Rabies Vaccine Product
Table 79. GSK (Novartis) Recent Development
Table 80. Sanofi-Pasteur Corporation Information
Table 81. Sanofi-Pasteur Description and Business Overview
Table 82. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Sanofi-Pasteur Rabies Vaccine Product
Table 84. Sanofi-Pasteur Recent Development
Table 85. Chengda Corporation Information
Table 86. Chengda Description and Business Overview
Table 87. Chengda Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Chengda Rabies Vaccine Product
Table 89. Chengda Recent Development
Table 90. Yisheng Corporation Information
Table 91. Yisheng Description and Business Overview
Table 92. Yisheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Yisheng Rabies Vaccine Product
Table 94. Yisheng Recent Development
Table 95. Prcmise Corporation Information
Table 96. Prcmise Description and Business Overview
Table 97. Prcmise Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Prcmise Rabies Vaccine Product
Table 99. Prcmise Recent Development
Table 100. VACN Corporation Information
Table 101. VACN Description and Business Overview
Table 102. VACN Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. VACN Rabies Vaccine Product
Table 104. VACN Recent Development
Table 105. Changsheng Corporation Information
Table 106. Changsheng Description and Business Overview
Table 107. Changsheng Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Changsheng Rabies Vaccine Product
Table 109. Changsheng Recent Development
Table 110. BCHT Corporation Information
Table 111. BCHT Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. BCHT Description and Business Overview
Table 113. BCHT Rabies Vaccine Product
Table 114. BCHT Recent Development
Table 115. Hissen Corporation Information
Table 116. Hissen Rabies Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Hissen Description and Business Overview
Table 118. Hissen Rabies Vaccine Product
Table 119. Hissen Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Rabies Vaccine Distributors List
Table 123. Rabies Vaccine Customers List
Table 124. Rabies Vaccine Market Key Trends
Table 125. Rabies Vaccine Key Opportunities and Drivers
Table 126. Rabies Vaccine Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Vaccine Product Picture
Figure 2. Global Rabies Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Rabies Vaccine Market Share by Application in 2020 & 2026
Figure 6. Pre-exposure Prophylaxis Examples
Figure 7. Post-exposure Prophylaxis Examples
Figure 8. Global Rabies Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Rabies Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Rabies Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Rabies Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Rabies Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Rabies Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Rabies Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Rabies Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Rabies Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Rabies Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Rabies Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Rabies Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Rabies Vaccine Players Market Share by Revenue in Rabies Vaccine 2015 & 2019
Figure 26. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Rabies Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Rabies Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Rabies Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Rabies Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Rabies Vaccine Sales Market Share by Type in 2019
Figure 32. United States Rabies Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Rabies Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Rabies Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Rabies Vaccine Sales Market Share by Application in 2019
Figure 36. China Rabies Vaccine Sales Market Share by Company in 2019
Figure 37. China Rabies Vaccine Sales Market Share by Type in 2019
Figure 38. China Rabies Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Rabies Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Rabies Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Rabies Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Rabies Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Rabies Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Rabies Vaccine Sales Market Share by Application in 2019
Figure 45. India Rabies Vaccine Sales Market Share by Company in 2019
Figure 46. India Rabies Vaccine Sales Market Share by Type in 2019
Figure 47. India Rabies Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Rabies Vaccine
Figure 50. Manufacturing Process Analysis of Rabies Vaccine
Figure 51. Rabies Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
犬用ワクチンの世界市場レポート2020 Market Analysis and Insights: Global Dog Vaccine Market The global Dog Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Dog Vaccine Scope and Market Size The global Dog Vaccine market is segmented by company, reg…- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- 23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …